Middle ear infection in children is much more common than in adults, in part because of how this part of the ear is designed.

Emapalumab is approved for both adults and pediatric (newborn and older) patients with MAS in Still disease with an inadequate response or intolerance to glucocorticoids, or with recurrent MAS.

Ear Infection. Centers for Disease Control and Prevention. July 1, 2021. Sarrell EM, Cohen HA, Kahan E. Naturopathic Treatment for Ear Pain in Children. Pediatrics. May 2003. Ear Infection (Middle ...

Sobi® (STO: SOBI) today announced that the U.S. Food and Drug Administration (FDA) approved Gamifant® (emapalumab-lzsg) for the treatment of adult and pediatric (newborn and older) patients with ...

The FDA has approved Gamifant as the first-ever treatment for macrophage activation syndrome in Still’s disease for adults ...

The approval was supported by pooled data from 2 open-label, single arm trials: the phase 2 NI-0501-06 study and the phase 3 EMERALD trial.

Treatment with salanersen slowed neurodegeneration and improved motor function in children with SMA in a Phase 1 trial, ...

Stockholm, Sweden Monday, June 30, 2025, 10:00 Hrs [IST] ...

What you need to know Has your child ever had chickenpox? Learn about the possible causes, symptoms, and treatments for ...

A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch ...

Diabetes is one of the most common health conditions in the world, which can cause serious complications and manifest as skin ...

Serious concerns continue to mount over the impact of HIV in Fiji, as eight children were among the 126 people who died from ...